Obstructive Sleep Apnea — New Perspective on Exploring the Post-apneic BP Surge in Patients With OSA
Citation(s)
Gesche H, Grosskurth D, Kuchler G, Patzak A Continuous blood pressure measurement by using the pulse transit time: comparison to a cuff-based method. Eur J Appl Physiol. 2012 Jan;112(1):309-15. doi: 10.1007/s00421-011-1983-3. Epub 2011 May 10.
Kim YS, Kim SY, Park DY, Wu HW, Hwang GS, Kim HJ Clinical Implication of Heart Rate Variability in Obstructive Sleep Apnea Syndrome Patients. J Craniofac Surg. 2015 Jul;26(5):1592-5. doi: 10.1097/SCS.0000000000001782.
Meglic B, Danieli A Glyceryl trinitrate-induced blood pressure variability decrease during head-up tilt test predicts vasovagal response. Blood Press Monit. 2023 Oct 1;28(5):236-243. doi: 10.1097/MBP.0000000000000653. Epub 2023 Jun 19.
Smith RP, Veale D, Pepin JL, Levy PA Obstructive sleep apnoea and the autonomic nervous system. Sleep Med Rev. 1998 May;2(2):69-92. doi: 10.1016/s1087-0792(98)90001-6.
Sun B, Ma Q, Shen J, Meng Z, Xu J Up-to-date advance in the relationship between OSA and stroke: a narrative review. Sleep Breath. 2023 Aug 26. doi: 10.1007/s11325-023-02904-2. Online ahead of print.
Xu J, Ding N, Chen L, Zhang Y, Huang M, Wang Y, Meng Z, Zhang X Inducers of post-apneic blood pressure fluctuation monitored by pulse transfer time measurement in obstructive sleep apnea varied with syndrome severity. Sleep Breath. 2019 Sep;23(3):769-776. doi: 10.1007/s11325-018-1770-z. Epub 2019 Jan 12.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
